| Monica Gardner, FNP | |
|
120 La Casa Via Ste 208, Walnut Creek, CA 94598-3007 | |
| (925) 935-5356 | |
| (925) 935-1070 |
| Full Name | Monica Gardner |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 120 La Casa Via Ste 208, Walnut Creek, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063785426 | NPI | - | NPPES |
| 19694 | Other | CA | CALIFORNIA NURSE PRACTITIONER LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 19694 (California) | Primary |
| Entity Name | Bass Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174253405 PECOS PAC ID: 9032111281 Enrollment ID: O20070201000181 |
News Archive
ArmaGen, Inc., a privately held biotechnology company focused on developing novel therapies to treat severe neurological disorders, announced today that the Investigational New Drug (IND) application for the company's lead product candidate, AGT-182 for the treatment of Hunter syndrome, has been accepted by the U.S. Food and Drug Administration and is now active.
An international research team led by the University of British Columbia (UBC) has uncovered for the first time the importance of a small gland tucked behind the sternum that works to prevent miscarriage and diabetes in pregnant women.
Bioengineers at the University of Pennsylvania have created a system to control the flexibility of the substrate surfaces on which cells are grown without changing the surface properties, providing a technique for more controlled lab experiments on cellular mechanobiology, an important step in the scientific effort to understand how cells sense and respond to mechanical forces in their environment.
Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.
US Oncology, Inc., the nation's leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla. Dec. 4-7. Five other investigators in the US Oncology Research Network participated in a study that will be displayed as a poster during the conference.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Monica Gardner, FNP 110 Tampico Ste 220, Walnut Creek, CA 94598-2962 Ph: (925) 935-5356 | Monica Gardner, FNP 120 La Casa Via Ste 208, Walnut Creek, CA 94598-3007 Ph: (925) 935-5356 |
News Archive
ArmaGen, Inc., a privately held biotechnology company focused on developing novel therapies to treat severe neurological disorders, announced today that the Investigational New Drug (IND) application for the company's lead product candidate, AGT-182 for the treatment of Hunter syndrome, has been accepted by the U.S. Food and Drug Administration and is now active.
An international research team led by the University of British Columbia (UBC) has uncovered for the first time the importance of a small gland tucked behind the sternum that works to prevent miscarriage and diabetes in pregnant women.
Bioengineers at the University of Pennsylvania have created a system to control the flexibility of the substrate surfaces on which cells are grown without changing the surface properties, providing a technique for more controlled lab experiments on cellular mechanobiology, an important step in the scientific effort to understand how cells sense and respond to mechanical forces in their environment.
Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.
US Oncology, Inc., the nation's leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla. Dec. 4-7. Five other investigators in the US Oncology Research Network participated in a study that will be displayed as a poster during the conference.
› Verified 1 days ago
Carmen Ka Man Yung, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1479 Ygnacio Valley Rd Ste 150, Walnut Creek, CA 94598 Phone: 925-296-7340 | |
Mrs. Rachael Marie Cabreira, MSN-FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1656 N California Blvd, 115, Walnut Creek, CA 94596 Phone: 925-941-7900 | |
Ms. Almita Heramia, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 450 N Wiget Ln, Walnut Creek, CA 94598 Phone: 925-691-9806 Fax: 925-691-9807 | |
Maki Matsumura, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1450 Treat Blvd Ste 250a, Walnut Creek, CA 94597 Phone: 925-296-9740 Fax: 925-296-9062 | |
Ms. Angela Christian, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 La Casa Via, Suite 209, Walnut Creek, CA 94598 Phone: 925-935-6252 Fax: 925-935-7611 | |
Reena Cho, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 110 Tampico Ste 210, Walnut Creek, CA 94598 Phone: 925-935-6952 Fax: 925-935-1396 | |
Mr. Terence Koontzy, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 738 Bancroft Rd, Walnut Creek, CA 94598 Phone: 925-938-8525 |